Skip to main content

Haemonetics Corp

HAE
Exchange
NYSE
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0000313143

No open-market purchases or sales by Haemonetics Corp insiders were filed in the last 90 days; 329 institutions reported holding it in 13F filings for Q2 2026, worth $3.71B in total; no superinvestor holds it.

Superinvestors holding HAE, Q2 2026

See all superinvestors

No superinvestor reported holding HAE in Q2 2026.

Moves by quarter

Superinvestors that opened, added to, trimmed or sold out of HAE each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.

  1. Q2 2024

    0 superinvestors holding at quarter end

    Sold out
    Maverick Capital
  2. Q1 2024

    1 superinvestor holding at quarter end

    New
    Maverick Capital
  3. Q2 2021

    0 superinvestors holding at quarter end

    Sold out
    Soros Fund Management